| Product Code: ETC8274341 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico CAR-T Cell Therapy Treatment Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico CAR-T Cell Therapy Treatment Market - Industry Life Cycle |
3.4 Mexico CAR-T Cell Therapy Treatment Market - Porter's Five Forces |
3.5 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Structure, 2021 & 2031F |
3.7 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Targeted Antigens, 2021 & 2031F |
3.8 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Brand, 2021 & 2031F |
3.9 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F |
4 Mexico CAR-T Cell Therapy Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Mexico |
4.2.2 Advancements in biotechnology and cell therapy research |
4.2.3 Growing investments in healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with CAR-T cell therapy treatment |
4.3.2 Limited awareness and accessibility to CAR-T cell therapy in Mexico |
5 Mexico CAR-T Cell Therapy Treatment Market Trends |
6 Mexico CAR-T Cell Therapy Treatment Market, By Types |
6.1 Mexico CAR-T Cell Therapy Treatment Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Autologous CAR-T Cells, 2021- 2031F |
6.1.4 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Allogeneic CAR-T Cells, 2021- 2031F |
6.2 Mexico CAR-T Cell Therapy Treatment Market, By Structure |
6.2.1 Overview and Analysis |
6.2.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By First Generation CAR-T Cells, 2021- 2031F |
6.2.3 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Second Generation Car-T Cells, 2021- 2031F |
6.2.4 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Third Generation CAR-T Cells, 2021- 2031F |
6.2.5 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Fourth Generation CAR-T Cells, 2021- 2031F |
6.3 Mexico CAR-T Cell Therapy Treatment Market, By Targeted Antigens |
6.3.1 Overview and Analysis |
6.3.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Solid Tumors, 2021- 2031F |
6.3.3 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Antigens on Hematologic Malignancies, 2021- 2031F |
6.4 Mexico CAR-T Cell Therapy Treatment Market, By Brand |
6.4.1 Overview and Analysis |
6.4.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Yescarta, 2021- 2031F |
6.4.3 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Kymriah, 2021- 2031F |
6.4.4 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Tecartus, 2021- 2031F |
6.5 Mexico CAR-T Cell Therapy Treatment Market, By Therapeutic Application |
6.5.1 Overview and Analysis |
6.5.2 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Hematological Malignancies, 2021- 2031F |
6.5.3 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Pancreatic Cancer, 2021- 2031F |
6.5.4 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.5.5 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.5.6 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.5.7 Mexico CAR-T Cell Therapy Treatment Market Revenues & Volume, By Multiple Myeloma, 2021- 2031F |
7 Mexico CAR-T Cell Therapy Treatment Market Import-Export Trade Statistics |
7.1 Mexico CAR-T Cell Therapy Treatment Market Export to Major Countries |
7.2 Mexico CAR-T Cell Therapy Treatment Market Imports from Major Countries |
8 Mexico CAR-T Cell Therapy Treatment Market Key Performance Indicators |
8.1 Average waiting time for CAR-T cell therapy treatment |
8.2 Number of clinical trials and research studies on CAR-T cell therapy in Mexico |
8.3 Adoption rate of CAR-T cell therapy among healthcare providers in Mexico |
9 Mexico CAR-T Cell Therapy Treatment Market - Opportunity Assessment |
9.1 Mexico CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mexico CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Structure, 2021 & 2031F |
9.3 Mexico CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Targeted Antigens, 2021 & 2031F |
9.4 Mexico CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Brand, 2021 & 2031F |
9.5 Mexico CAR-T Cell Therapy Treatment Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F |
10 Mexico CAR-T Cell Therapy Treatment Market - Competitive Landscape |
10.1 Mexico CAR-T Cell Therapy Treatment Market Revenue Share, By Companies, 2024 |
10.2 Mexico CAR-T Cell Therapy Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here